MULTIPLE PATTERNS OF MDM-2 DEREGULATION IN HUMAN LEUKEMIAS - IMPLICATIONS IN LEUKEMOGENESIS AND PROGNOSIS

被引：40

作者：

BUESORAMOS, CE ^{[1
]}

MANSHOURI, T ^{[1
]}

HAIDAR, MA ^{[1
]}

HUH, YO ^{[1
]}

KEATING, MJ ^{[1
]}

ALBITAR, M ^{[1
]}

机构：

[1] UNIV TEXAS,MD ANDERSON CANCER CTR,DIV LAB MED,HEMATOPATHOL PROGRAM,HOUSTON,TX 77030

来源：

LEUKEMIA & LYMPHOMA | 1995年 / 17卷 / 1-2期

关键词：

MDM-2; ISOFORMS; LEUKEMIA; GENE DEREGULATION; RT-PCR;

D O I：

10.3109/10428199509051698

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The human analogue of the mouse double minute-2 (MDM-2) protein binds to p53 protein and abrogates its tumor-suppressing activity. MDM-2 overexpression may represent an alternative mechanism to p53 mutation for escaping the p53-mediated growth control. Interestingly, multiple MDM-2 protein isoforms have been described and the possibility of functional differences between various isoforms has been raised. Previously, we demonstrated significant MDM-2 mRNA overexpression in human leukemias and suggested that MDM-2 overexpression may be a marker of aggressiveness of the disease. Polyclonal antibodies (Ab) have been generated to detect various isoforms of the MDM-2 protein. Using these Abs, we confirmed MDM-2 protein overexpression in leukemias. Furthermore, we observed heterogeneity in the isoforms expressed in various types of leukemias. In addition, we demonstrated that analysis by flow cytometry could be used as a diagnostic tool for detecting altered MDM-2 protein expression in leukemias. Here we review and expand our initial observations and confirm MDM-2 mRNA and protein overexpression by reverse transcription-polymerase chain reaction (RT-PCR), flow cytometry, and western blot analyses. Understanding the possible role of MDM-2 oncogene expression in leukemias may establish the scientific basis for new therapeutic approaches.

引用

页码：13 / 18

页数：6

共 35 条

[31] Sheikh M.S., Shao Z.-M., Hussain A., Fontana J.A., The p53-binding protein MDM-2 gene is differentially expressed in human breast carcinoma, Cancer Res., 53, pp. 3226-3228, (1993)
[32] Albitar M., Katsumata M., Liebhaber S.A., Human ct-globin genes demonstrate autonomous developmental regulation in transgenic mice, Mol. Cell Biol., 11, (1991)
[33] Estes P.A., Cook N.E., Liebhaber S.A., A difference in the splicing patterns of the closely related normal and variant human growth hormone gene transcripts is determined by a minimal sequence divergence between two potential splice-acceptor sites, J. Biol. Chem., 265, (1990)
[34] Binet J.-L., Catovsky D., Chadra P., Dighiero G., Montserrat T.E., Rai K.R., Sawitsky A., Chronic lymphocytic leukemia: Proposals for a revised prognostic staging system, Br. J. Haematol., 48, pp. 365-367, (1981)
[35] Samuels B.L., Larson R.A., Le Beau M.M., Daly K.M., Bitter M.A., Vardiman J.W., Barker C.M., Rowley J.D., Golomb H.M., Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo, Leukemia, 2, pp. 79-83, (1988)

← 1 2 3 4 →